Cefepime Induced Encephalopathy Mimicking Acute Stroke
Journal of the Korean Neurological Association
; : 372-375, 2019.
Article
ي Ko
| WPRIM
| ID: wpr-766822
المكتبة المسؤولة:
WPRO
ABSTRACT
Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.
Key words
النص الكامل:
1
الفهرس:
WPRIM
الموضوع الرئيسي:
Seizures
/
United States Food and Drug Administration
/
Brain Diseases
/
Stroke
/
Myoclonus
المحددات:
Aged
/
Aged80
/
Female
/
Humans
اللغة:
Ko
مجلة:
Journal of the Korean Neurological Association
السنة:
2019
نوع:
Article